Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M, Hamelin R, Yamamoto H, Hofstra RM, Seruca R, Lindblom A, Peltomäki P, Thibodeau SN, Aaltonen LA, Schwartz S Jr.

J Med Genet. 2004 Sep;41(9):664-8.

2.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

3.

Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.

Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB.

J Med Genet. 2012 Mar;49(3):151-7. doi: 10.1136/jmedgenet-2011-100714. Review.

PMID:
22368298
4.
5.

BRAF mutation testing in colorectal cancer.

Sharma SG, Gulley ML.

Arch Pathol Lab Med. 2010 Aug;134(8):1225-8. doi: 10.1043/2009-0232-RS.1. Review.

PMID:
20670148
6.

[Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].

Olschwang S, Bonaïti C, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-Puig P, Lecuru F, Millat B, Sobol H, Thomas G, Eisinger F.

Bull Cancer. 2004 Apr;91(4):303-15. Review. French.

7.

[Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].

Olschwang S, Bonaïti-Pellié C, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-Puig P, Lecuru F, Millat B, Sobol H, Thomas G, Eisinger F.

Pathol Biol (Paris). 2006 May;54(4):215-29. Epub 2006 May 4. Review. French.

PMID:
16677780
8.

Genetic susceptibility to non-polyposis colorectal cancer.

Lynch HT, de la Chapelle A.

J Med Genet. 1999 Nov;36(11):801-18. Review.

9.

[HNPCC syndrome (hereditary non polyposis colon cancer): identification and management].

Olschwang S, Bonaïti C, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-Puig P, Lecuru F, Millat B, Sobol H, Thomas G, Eisinger F.

Rev Med Interne. 2005 Feb;26(2):109-18. Review. French.

PMID:
15710257
10.
11.

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.

Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN.

Genet Med. 2009 Jan;11(1):42-65. doi: 10.1097/GIM.0b013e31818fa2db. Review. No abstract available.

Supplemental Content

Support Center